Tongjitang Chinese Medicines Co. (ADR) (NYSE:TCM)

CAPS Rating: 3 out of 5

A vertically integrated and profitable specialty pharmaceutical company focusing on the development, manufacturing and marketing of modernized traditional Chinese medicine.

Recs

0
Player Avatar porcelain808 (34.28) Submitted: 4/29/2008 8:20:41 PM : Outperform Start Price: $8.22 TCM Score: -44.17

Buyout or not, this looks good.

Featured Broker Partners


Advertisement